Zhang YY et al. |
Osteoprotegerin Promotes Cementoblastic Activity of Murine Cementoblast Cell Line in vitro. |
2016 |
Chin J Dent Res |
pmid:27379348
|
Nagy EE et al. |
High circulating osteoprotegerin levels are associated with non-zero blood groups. |
2016 |
BMC Cardiovasc Disord |
pmid:27387019
|
|
|
|
|
pmid:27391172
|
|
|
|
|
pmid:27394662
|
|
|
|
|
pmid:27409364
|
Pellegrini GG et al. |
Avenanthramides Prevent Osteoblast and Osteocyte Apoptosis and Induce Osteoclast Apoptosis in Vitro in an Nrf2-Independent Manner. |
2016 |
Nutrients |
pmid:27409635
|
Ugay L et al. |
Role of Osteoprotegerin and Receptor Activator of Nuclear Factor-κB Ligand in Bone Loss Related to Advanced Chronic Obstructive Pulmonary Disease. |
2016 |
Chin. Med. J. |
pmid:27411457
|
|
|
|
|
pmid:27421098
|
|
|
|
|
pmid:27430581
|
|
|
|
|
pmid:27441597
|
Zhao JJ et al. |
MicroRNA-145 Mediates Steroid-Induced Necrosis of the Femoral Head by Targeting the OPG/RANK/RANKL Signaling Pathway. |
2016 |
PLoS ONE |
pmid:27459539
|
|
|
|
|
pmid:27460567
|
Piemontese M et al. |
Cortical bone loss caused by glucocorticoid excess requires RANKL production by osteocytes and is associated with reduced OPG expression in mice. |
2016 |
Am. J. Physiol. Endocrinol. Metab. |
pmid:27460899
|
Yu M et al. |
Chemotherapy effectively suppresses interleukin-20, receptor activator of nuclear factor kappa-B ligand, and osteoprotegerin levels in patients with lung adenocarcinoma and bone metastasis. |
2016 Apr-Jun |
J Cancer Res Ther |
pmid:27461682
|
|
|
|
|
pmid:27463412
|
Røysland R et al. |
Diagnostic and Prognostic Properties of Osteoprotegerin in Patients with Acute Dyspnoea: Observations from the Akershus Cardiac Examination (ACE) 2 Study. |
2016 |
PLoS ONE |
pmid:27463973
|
|
|
|
|
pmid:27469295
|
|
|
|
|
pmid:27475026
|
Jung YJ et al. |
Tannerella forsythia GroEL induces inflammatory bone resorption and synergizes with interleukin-17. |
2017 |
Mol Oral Microbiol |
pmid:27484636
|
|
|
|
|
pmid:27491024
|
|
|
|
|
pmid:27493142
|
|
|
|
|
pmid:27501819
|
|
|
|
|
pmid:27503623
|
|
|
|
|
pmid:27505721
|
Qian H et al. |
FSH aggravates bone loss in ovariectomised rats with experimental periapical periodontitis. |
2016 |
Mol Med Rep |
pmid:27510616
|
|
|
|
|
pmid:27515196
|
Yongdi L et al. |
[Osteoprotegerin/receptor activator of nuclear factor-κB ligand expression in mandibular distraction osteogenesis regulated by parathyroid hormone]. |
2016 |
Hua Xi Kou Qiang Yi Xue Za Zhi |
pmid:27526445
|
|
|
|
|
pmid:27541035
|
|
|
|
|
pmid:27552373
|
|
|
|
|
pmid:27563728
|
|
|
|
|
pmid:27571745
|
Sun J et al. |
Daidzein increases OPG/RANKL ratio and suppresses IL-6 in MG-63 osteoblast cells. |
2016 |
Int. Immunopharmacol. |
pmid:27576059
|
|
|
|
|
pmid:27582133
|
|
|
|
|
pmid:27599364
|
Xing R et al. |
Interleukin-21 promotes osteoclastogenesis in RAW264.7 cells through the PI3K/AKT signaling pathway independently of RANKL. |
2016 |
Int. J. Mol. Med. |
pmid:27599586
|
|
|
|
|
pmid:27608363
|
|
|
|
|
pmid:27608613
|
Menzel J et al. |
Association between omentin-1, adiponectin and bone health under consideration of osteoprotegerin as possible mediator. |
2016 |
J. Endocrinol. Invest. |
pmid:27614458
|
Shirakawa J and Kulkarni RN |
Novel factors modulating human β-cell proliferation. |
2016 |
Diabetes Obes Metab |
pmid:27615134
|
|
|
|
|
pmid:27639566
|
|
|
|
|
pmid:27647720
|
|
|
|
|
pmid:27650950
|
|
|
|
|
pmid:27651300
|
|
|
|
|
pmid:27663616
|
|
|
|
|
pmid:27664484
|
|
|
|
|
pmid:27665233
|
|
|
|
|
pmid:27684563
|
|
|
|
|
pmid:27692945
|
Li M et al. |
Heparan Sulfate Regulates the Structure and Function of Osteoprotegerin in Osteoclastogenesis. |
2016 |
J. Biol. Chem. |
pmid:27697839
|
|
|
|
|
pmid:27710796
|